Singapore Pharmaceuticals and Healthcare - Report Q4 2014

Business Monitor International
September 3, 2014
129 Pages - SKU: BMI5321336
Countries covered: Singapore

Singapore Pharmaceuticals and Healthcare - Report Q4 2014

BMI View: While Singapore's small population will limit the pharmaceutical market's overall growthpotential, the government's commitment to healthcare as well as the ageing population will boostconsumption of pharmaceuticals over the long term. In addition, the impending launch of the Association ofSouth East Asian Nations Community in 2015 will increase Singapore's attractiveness to foreignpharmaceutical firms.

Headline Expenditure Projections

Pharmaceuticals: SGD990mn (USD790mn) in 2013 to SGD1.04bn (USD830mn) in 2014; +5.5% inlocal currency terms and +5.0% in US dollar terms. Forecast unchanged from Q314.

Healthcare: SGD17.78bn (USD14.21bn) in 2013 to SGD19.33bn (USD15.38bn) in 2014; +8.7% in localcurrency terms and +8.3% in US dollar terms. Forecast slightly downgraded from Q314.

More Prescription Drugs reports by Business Monitor International

Pharmaceuticals and Healthcare Report - Russia Q4 2104 by Business Monitor International
BMI View: Russia's cooling of relations with the West is putting pressure on foreign investment in thecountry. With the EU and the US applying further ...
Pharmaceuticals and Healthcare Report - Greece Q4 2104 by Business Monitor International
BMI View: The pharmaceutical and healthcare industry in Greece will continue to contract over theremainder of 2014. The government will seek to reduce public spending ...
Pharmaceuticals and Healthcare Report - Finland Q4 2104 by Business Monitor International
BMI View: An ageing population and the subsequent increased consumption of high-value prescriptionmedicines for the treatment of long-term illnesses will place a greater strain on ...
Pharmaceuticals and Healthcare Report - Oman Q4 2014 by Business Monitor International
BMI View: Despite its small size in comparison with other GCC countries, Oman will remain an attractivemarket to multinational pharmaceutical companies due to the high ...
See all reports like this >>

More Singapore Prescription Drugs reports

Singapore Pharmaceutical Industry Report - 2014 by Emerging Markets Direct Reports
Singapore Pharmaceutical Industry Report - 2014This report profiles Singapore’s pharmaceutical industry, analyzing sector size and performance, competitive landscape, recent development in the industry as well ...
Singapore Healthcare Industry 2H12 by Emerging Markets Direct Reports
Singapore: Healthcare covers the Asia-Pacific overview, general overview of Singapore, and Singapore healthcare industry including social development and healthcare services. It also covers the market ...
Antibiotics Market in Singapore to 2016 by Global Research & Data Services
This market research report offers a perspective on the actual market situation, trends and future outlook for antibiotics in Singapore. The study provides essential market ...
The Pharmaceutical Market: Singapore by Espicom Healthcare Intelligence
Espicom's highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting ...
See all reports like this >>



    Report with 3 quarterly updates  USD 1,295  
    Report with 3 quarterly updates
3 User License
  USD 1,945  
    Report with 3 quarterly updates
5 User License
  USD 2,500  
    Report with 3 quarterly updates
Departmental/Site License
  USD 2,995  
    Global Site License Fulfilled by Publisher  USD 6,995  
US: 800.298.5699
Int'l: +1.240.747.3093

Share this report

    Other tasks

    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!